.png){kind=logo}
If work performed for you at the San Diego CFAR Translational Virology Core results in publication, please acknowledge us with the following statement and please e-mail a PDF of your publication to the Core Administrator:
Faculty and Staff of the Translational Virology Core please use the following acknowledgement statement for our publications:
This work was supported by the Department of Veterans Affairs and grants from the National Institutes of Health.
DK131532 (R01 Smith - Gut); AI169609 (P01 Smith - HOME); DA047039 (R33 Smith - Opioid Impacts); AI131385 (P01 Smith - R3 Rebound); AI100665 (Smith - K24 Training); AI036214 (Smith - CFAR); AI126620 (Smith - BEAT-HIV Delaney Collaboratory); AI164570 (Montaner - BEAT-HIV Delaney Collaboratory); AI007384 (HOPE - T32 Training); MH062512 (Heaton - HNRC); AI106039 (Little - PIRC); AI147821 (Gianella - CMV Replication on HIV Persistence); DA051915 (Gianella – Avenir: HIV-Associated Opioid Micro-Environment [HOME]); AI164559 (Gianella - HOPE Collaboratory); AI158293 (R56 Gianella- Reproductive Aging HIV Persistence); DA055491 (R01 Chaillon - Myeloid Cells HIV-associated Damage and Viral Dispersal); OD026565 (K01 LaMere - Comparative Retroviral Epigenomics); AI162225 (R21 LaMere - Impact Proviral Epigenetics on HIV-1 Rebound); AI068636 (Currier - ACTG); CA023100 (Lippman-Specialized Cancer Center Support grant).
The following grants also contributed support:
The James B. Pendleton Charitable Trust; IN-US-292-4217 (Little - NIH/Gilead, Deep-Sequencing of HIV-1: M184I/V study); MISP#60300 (Chaillon - Merck, Pooled nucleic acid testing SARS-CoV-2)